$4.96
0.00% today
NYSE, Apr 03, 06:50 pm CET
ISIN
US9013841070
Symbol
TSVT
Sector
Industry

2seventy bio Stock price

$4.96
+2.48 100.00% 1M
+0.15 3.12% 6M
+2.02 68.71% YTD
+0.02 0.40% 1Y
-13.85 73.63% 3Y
-8.81 63.98% 5Y
-8.81 63.98% 10Y
NYSE, Closing price Wed, Apr 02 2025
+0.01 0.20%
ISIN
US9013841070
Symbol
TSVT
Sector
Industry

Key metrics

Market capitalization $259.60m
Enterprise Value $328.57m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 8.68
P/S ratio (TTM) P/S ratio 6.86
P/B ratio (TTM) P/B ratio 1.21
Revenue growth (TTM) Revenue growth -62.28%
Revenue (TTM) Revenue $37.86m
EBIT (operating result TTM) EBIT $-105.54m
Free Cash Flow (TTM) Free Cash Flow $-85.71m
Cash position $174.75m
EPS (TTM) EPS $-1.12
P/E forward negative
P/S forward 3.79
EV/Sales forward 4.80
Short interest 7.65%
Show more

Is 2seventy bio a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

2seventy bio Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a 2seventy bio forecast:

3x Hold
100%

Analyst Opinions

3 Analysts have issued a 2seventy bio forecast:

Hold
100%

Financial data from 2seventy bio

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
38 38
62% 62%
100%
- Direct Costs 30 30
9% 9%
78%
8.20 8.20
89% 89%
22%
- Selling and Administrative Expenses 37 37
38% 38%
97%
- Research and Development Expense 70 70
68% 68%
184%
-98 -98
52% 52%
-260%
- Depreciation and Amortization 7.10 7.10
31% 31%
19%
EBIT (Operating Income) EBIT -106 -106
51% 51%
-279%
Net Profit -57 -57
74% 74%
-151%

In millions USD.

Don't miss a Thing! We will send you all news about 2seventy bio directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

2seventy bio Stock News

Neutral
Business Wire
9 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the fourth quarter and full year ended December 31, 2024. “2024 was a pivotal year for 2seventy as we made significant changes to our business to streamline cost structure and focus solely on Abecma,” said Chip Baird, chief executive officer, 2seventy bio. “This week ...
Neutral
Business Wire
20 days ago
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of 2seventy bio, Inc. (NasdaqGS: TSVT) to Bristol Myers Squibb (NYSE: BMY). Under the terms of the proposed transaction, shareholders of 2seventy will receive $5.00 in cash for each share of 2seventy ...
Neutral
Business Wire
23 days ago
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating 2seventy bio (Nasdaq: TSVT) for possible breaches of fiduciary duty and other violations of law in its transaction with Bristol Myers Squibb. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the ...
More 2seventy bio News

Company Profile

2seventy Bio, Inc. operates as cell and gene therapy company. It is focused on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.

Head office United States
CEO Chip Baird
Employees 65
Founded 2021
Website www.2seventybio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today